These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes. Jinnouchi Y, Yamagishi S, Takeuchi M, Ishida S, Jinnouchi Y, Jinnouchi J, Imaizumi T. Clin Exp Med; 2006 Dec; 6(4):191-3. PubMed ID: 17191111 [No Abstract] [Full Text] [Related]
17. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Santilli F, Bucciarelli L, Noto D, Cefalù AB, Davì V, Ferrante E, Pettinella C, Averna MR, Ciabattoni G, Davì G. Free Radic Biol Med; 2007 Nov 01; 43(9):1255-62. PubMed ID: 17893038 [Abstract] [Full Text] [Related]
18. Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial). Lloret R, Ycas J, Stein M, Haffner S, STARSHIP Study Group. Am J Cardiol; 2006 Sep 15; 98(6):768-73. PubMed ID: 16950182 [Abstract] [Full Text] [Related]